Vertex Pharmaceuticals Inc (VRTX)
450.97
+0.60
(+0.13%)
USD |
NASDAQ |
Nov 22, 16:00
451.02
+0.05
(+0.01%)
After-Hours: 20:00
Vertex Pharmaceuticals Free Cash Flow: -1.352B for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| September 30, 2024 | -1.352B |
| June 30, 2024 | -1.426B |
| March 31, 2024 | 3.479B |
| December 31, 2023 | 3.279B |
| September 30, 2023 | 4.205B |
| June 30, 2023 | 3.879B |
| March 31, 2023 | 3.890B |
| December 31, 2022 | 3.925B |
| September 30, 2022 | 3.814B |
| June 30, 2022 | 3.787B |
| March 31, 2022 | 2.451B |
| December 31, 2021 | 2.408B |
| September 30, 2021 | 1.919B |
| June 30, 2021 | 1.777B |
| March 31, 2021 | 3.048B |
| December 31, 2020 | 2.994B |
| September 30, 2020 | 2.979B |
| June 30, 2020 | 2.557B |
| March 31, 2020 | 1.983B |
| December 31, 2019 | 1.494B |
| September 30, 2019 | 1.364B |
| June 30, 2019 | 1.414B |
| March 31, 2019 | 1.258B |
| December 31, 2018 | 1.175B |
| September 30, 2018 | 1.060B |
| Date | Value |
|---|---|
| June 30, 2018 | 682.12M |
| March 31, 2018 | 554.31M |
| December 31, 2017 | 585.52M |
| September 30, 2017 | 530.93M |
| June 30, 2017 | 600.58M |
| March 31, 2017 | 461.24M |
| December 31, 2016 | 179.54M |
| September 30, 2016 | 66.22M |
| June 30, 2016 | -56.42M |
| March 31, 2016 | -205.05M |
| December 31, 2015 | -410.73M |
| September 30, 2015 | -623.81M |
| June 30, 2015 | -649.88M |
| March 31, 2015 | -665.82M |
| December 31, 2014 | -624.31M |
| September 30, 2014 | -422.57M |
| June 30, 2014 | -357.86M |
| March 31, 2014 | -220.96M |
| December 31, 2013 | -112.06M |
| September 30, 2013 | -104.83M |
| June 30, 2013 | 11.96M |
| March 31, 2013 | 117.56M |
| December 31, 2012 | 196.70M |
| September 30, 2012 | 738.52M |
| June 30, 2012 | 686.87M |
Free Cash Flow Range, Past 5 Years
-1.426B
Minimum
Jun 2024
4.205B
Maximum
Sep 2023
2.555B
Average
2.986B
Median
Free Cash Flow Benchmarks
| Eli Lilly and Co | -2.275B |
| Gilead Sciences Inc | 9.431B |
| Bristol-Myers Squibb Co | 13.80B |
| Moderna Inc | -3.956B |
| Pfizer Inc | 8.227B |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 1.370B |
| Cash from Investing (Quarterly) | -348.00M |
| Cash from Financing (Quarterly) | -387.50M |
| Free Cash Flow Per Share (Quarterly) | 4.989 |
| Free Cash Flow to Equity (Quarterly) | 1.302B |
| Free Cash Flow to Firm (Quarterly) | 1.302B |
| Free Cash Flow Yield | -1.15% |